More Business Wire
View Older Stories View Newer Stories-
BlackRock Introduces Three iShares ETFs to Customize Exposure to U.S. Large Caps
-
Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System
-
HarborOne Bancorp, Inc. Announces 2024 Third Quarter Results
-
Anumana Joins Accelerating Medicines Partnership Heart Failure Program to Advance ECG-AI™ Research
-
FREYR Battery Selected by European Union Innovation Fund for Grant Award
-
Amentum to Announce Fiscal Year 2024 Results, Host Conference Call December 17, 2024
-
Spectrum Healthcare Partners Leverages Pramana’s AI-Enabled Scanners to Bring Digital Pathology to Central Maine Healthcare
-
Iterative Health to Present Five Abstracts at ACG 2024 in Collaboration with Leaders in Gastrointestinal Scientific Community
-
Metropolitan Floors Tackles Industry Misconceptions About Acoustic Ratings in Condos and Stratas
-
Wolters Kluwer’s 2024 Future Ready Lawyer Survey: Legal Professionals Confident in Managing AI-Driven Changes to Business of Law
-
Bristol City Leap Wins 2024 Award of Distinction for Public-Private Collaboration in Cities
-
Data Vault Holdings Unveils DVHolo: A Next-Generation Hologram Product Suite Powered by ADIO® in Partnership with HYPERVSN
-
Evexta Bio Appoints Edith A. Perez as Scientific Advisor
-
Alliant Insurance Services Expands Midwest Team with Rob Grant
-
The Marygold Companies Acquires Ownership Stake in Savings and Loan Association Holding Company
-
Sensata Foundation Announces Nonprofit Awardees for 2024-2025 Grant Cycle
-
ModMed Introduces Automated Commissions Reporting Solution to Streamline Practice Management for Plastic Surgeons and Dermatologists
-
TriCo Bancshares Reports Third Quarter 2024 Net Income of $29.1 Million, Diluted EPS of $0.88
-
Alison Phoenix Promoted to Athens Branch Manager with National Bank of Coxsackie
-
Dermavant Presents Data on Achievement of No-to-Minimal Itch and Sleep Improvement in Atopic Dermatitis Patients as Young as Two Years Old at American College of Allergy, Asthma and Immunology Annual
-
Advance Auto Parts Announces Date for Third Quarter 2024 Earnings Release and Conference Call
-
NiKang Therapeutics® Presents Discovery of NKT3964, a First-in-Class, Highly Potent and Selective, Orally Bioavailable CDK2 PROTAC Degrader for Cancer Therapy, at the EORTC-NCI-AACR Symposium 2024
-
Apollon Holdings Expands National Presence with New Advisory Teams
-
Collective Renaissance Guild Releases 2024 Black Youth Study: A Look At Priorities In Georgia
-
BlueSnap Launches New Channel Partner Program, Expands System Integrator Network with Eight New Partners
-
Torus Unveils Integrated Energy Storage and AI-Driven Cybersecurity Solutions at 47G Zero Gravity Summit
-
Semtech Expands Smart Connectivity Advanced VoLTE Coverage
-
Adtran demonstrates Oscilloquartz assured PNT solution at Jammertest
-
MSCI Welcomes Richard Mattison as New Leader for ESG and Climate Business
-
New Report Reveals U.S. Family Caregivers Perform Equivalent of a Staggering $873.5 Billion Worth of Labor, Would Surpass Revenue of Top Global Companies
-
Yellowbrick Data and Coginiti Partner to Bring High-Performance Capabilities for Analytics, Business Intelligence and AI Workloads
-
Viant Announces Date of Third Quarter 2024 Financial Results and Conference Call
-
Amount Unveils AI Policy Optimizer for Lenders
-
Aria Billing Cloud to Support Gtd’s Business and Consumer Subscribers Across Latin America
-
PeoplesBank and Nymbus Set New Standards in Employer-Focused Financial Solutions
-
CroíValve Announces First Implant of a Novel Minimally Invasive Device for Tricuspid Regurgitation in US Early Feasibility Study
-
Takeda and Boston Medical Center Announce Innovative Collaboration to Help Tackle Decarbonization Across Health Care Ecosystem
-
Blue Sage Capital Invests In MHW
-
Redfin Reports Homebuying Demand Holds Up Even As Election Uncertainty, Stronger-Than-Expected Economy Push Up Rates
-
Sinaptica Therapeutics to Present Results of 52-week Phase 2 Study of Precision Neuromodulation for Alzheimer’s Diseases in Oral Presentation at Clinical Trials on Alzheimer’s Disease (CTAD) Confe
-
National Tree Co. Study Finds Strong Holiday Décor Demand Persists Despite Inflation Concerns
-
Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives
-
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
-
Cognosos Announces Acquisition of Cox Prosight to Enhance Real-Time Location Intelligence Solutions for Hospitals
-
Lateral Investment Management to Attend SuperReturn North America 2024
-
4imprint® Completes Expansion of Oshkosh Distribution Center
-
Cellino Appoints Chris Gibson to Board of Directors
-
Altium to Unveil Groundbreaking Industry Solution at Electronica 2024
-
Javelin Venture Partners Announces New Partners in $125 Million Fifth Fund
-
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
